Abstract: A radiolabeled lymphatic staining agent is mixed on site with a much larger amount, on a weight basis, of a non-radiolabeled lymphatic staining agent to form an injectable radiolabeled lymphatic staining agent suitable for surgical use in humans. Preferably, the radiolabel is I-125, because it has a 60-day half-life which enables it to be made off-site. The preferred radiolabeled lymphatic staining agent is iodinated methylene blue, because it can be mixed with a range of non-radioactive lymphatic staining agents, for example isosulfan blue, methylene blue, patent blue, and patent blue V, to provide the injected agent with sufficient radioactivity to enable machine detection. A method for making radioiodinated methylene blue is also disclosed.

Abstract: A radiolabeled lymphatic staining agent is mixed on site with a much larger amount, on a weight basis, of a non-radiolabeled lymphatic staining agent to form an injectable radiolabeled lymphatic staining agent suitable for surgical use in humans. Preferably, the radiolabel is I-125, because it has a 60-day half-life which enables it to be made off-site. The preferred radiolabeled lymphatic staining agent is iodinated methylene blue, because it can be mixed with a range of non-radioactive lymphatic staining agents, for example isosulfan blue, methylene blue, patent blue, and patent blue V, to provide the injected agent with sufficient radioactivity to enable machine detection. A method for making radioiodinated methylene blue is also disclosed.

Abstract: Undesirable metal cation contaminants, including hafnium, can be reduced from a solution containing Lutetium-177 on a bed of an anion exchange resin. The thus purified solution can be stored and transported in a polypropylene vial, to prevent the possibility of hafnium entering the solution from a glassware wall and of Lutetium from being lost from the solution by chemically reacting with a glassware wall. The vial can be sealed with a rubber stopper which has a polytetrafluoroethylene coating facing the solution to prevent the possibility of contaminants which could interfere with later uses of the Lutetium-177 from leaching into the solution from the rubber stopper. Recipients of the Lutetium-177-containing vial can be provided with a prepackaged column of the anion exchange resin to enable such recipients to remove the hafnium which accumulated in the solution as a product of radioactive decay during shipment.

Abstract: A composition of matter comprises a pathogen-targeting organic moiety which is conjugated to a radioisotope which has a half-life of less than 100 days. The composition can be synthesized by bringing together a radioisotope having a half life of less than 100 days with a greater than stoichiometric amount of a complexing agent so as to form a first mixture containing a reaction product between the radioisotope and the complexing agent; removing the excess complexing agent from the mixture; and bringing together the first reaction product and an antibody substance so as to form a second mixture containing a reaction product between the first reaction product and the antibody substance. The composition is useful for treating infectious diseases caused by pathogens.

Abstract: An environmentally sealed color filter is provided which includes a housing having a top side, a bottom side, a front side, a rear side, and a pair of lateral sides, the housing having a first window on the front side and a second window on the rear side. The housing is substantially water-proof or impermeable to water in that when submerged in water at depths of up to 50 feet and for time periods of up to 24 hours, no water will pass from the exterior of the housing to the interior of the housing. A color filter, such as the Color Fader™ color filter manufactured by Morpheus Technologies, LLC and described in U.S. Pat. No. 5,126,886, is secured within the housing. Also secured within the housing is at least one heat exchanger. The heat exchanger dissipates heat generated within the housing.

Abstract: Undesirable metal cation contaminants, including cadmium, can be removed from a solution containing Indium-111, on a bed of an anion exchange resin. The thus purified solution can be stored and transported in a polypropylene vial, to prevent the possibility of cadmium entering the solution from a glassware wall and of Indium from being lost from the solution by chemically reacting with a glassware wall. The vial can be sealed with a rubber stopper which has a polytetrafluroethylene coating facing the solution to prevent the possibility of contaminants which could interfere with later uses of the Indium-111 from leaching into the solution from the rubber stopper. Recipients of the Indium-111-containing vial can be provided with a prepackaged column of the anion exchange resin to enable such recipients to remove the cadmium which accumulated in the solution as a product of radioactive decay during shipment.

Abstract: Each embodiment of the slitter includes a handle member having an arcuate section joined thereto, a knife blade, a clamp member having a lower arcuate portion, and a hinge for joining the clamp and handle members for hinged movement between catheter clamping and release positions, each of the arcuate section and arcuate portion having transversely opposite facing surface portions for clampingly engaging diametrically opposite surface portions of any one of the number of different outer diameter catheters, and at least one of the arcuate section and arcuate portion having a nose portion for entering between the clamped catheter and the introducer when the introducer is to be removed from the catheter without being moved over the proximal terminal end of the catheter. The knife blade is located radially outwardly of the surfaces that abut against the clamped cather and extends radially outwardly of the nose and is located rearward of the forwardmost part of the nose.